How many clinical trials are running for dupilumab?

ClinicalTrials.gov lists more than 16 phase 2–4 dupilumab trials. This page tracks the 16 largest by enrolment: 2 phase 2, 9 phase 3, and 5 phase 4 among them, with 3 actively recruiting. Updated daily.

Are there clinical trials for Dupixent?

Dupixent is the brand name for dupilumab, so dupilumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 dupilumab trials. This page tracks the 16 largest by enrolment: 2 phase 2, 9 phase 3, and 5 phase 4 among them, with 3 actively recruiting. Updated daily.

Where does this data come from?

All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.

Can I compare dupilumab against other drugs?

Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Immunology & inflammation · Live ClinicalTrials.gov data

Dupilumab (Dupixent) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 dupilumab (Dupixent) trials on ClinicalTrials.gov by enrolment, 3 of them actively recruiting. The next phase 3 primary completion among them is expected May 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

Phase 3 trials

Actively recruiting

May 2027

Next phase 3 primary completion

8,615

Participants across trials

Regeneron Pharmaceuticals

Lead sponsor by trial count

dupilumab (16)8 active2013–2030

Hide completed

dupilumab

Key

Actual date

Anticipated

Forecast to primary completion

RecruitingActive, not recruitingNot yet recruitingCompleted

'13

'15

'17

'19

'21

'23

'25

'27

'29

dupilumab

Open-label Study of Dupilumab in Patients With Atopic DermatitisP3

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)P3

VENTUREP3

A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableP3

VOYAGEP3

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)P3

Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)P2

IDEAP4

Level UpP3

TORNADOP4

AIM4:Next StepP4

WIDUSAP4

A Phase Ⅲ Comparative Study of QL2108 to Dupixent®P3

Tapering of Biologics in Chronic Rhinosinusitis With Nasal PolypsP4

HOTHOTP3

A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic DermatitisP2

Upcoming readouts

7 ahead · dupilumab

Select a trial to load its full ClinicalTrials.gov record.

Key dupilumab trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

Trial	Title	Phase	Status	Primary completion
NCT07187583	Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps	Phase 4	Recruiting	Mar 2028
NCT05942222	TORNADO: A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Ch…	Phase 4	Active, not recruiting	Apr 2026
NCT03694158	IDEA: Investigating Dupilumab's Effect in Asthma by Genotype	Phase 4	Active, not recruiting	Jan 2027
NCT06572228	AIM4:Next Step: Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/…	Phase 4	Active, not recruiting	Apr 2027
NCT06818019	WIDUSA: Withdrawal of Dupilumab in Severe Asthma	Phase 4	Not yet recruiting	Dec 2027
NCT07309614	HOTHOT: A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma	Phase 3	Recruiting	Jan 2029
NCT06884891	A Phase Ⅲ Comparative Study of QL2108 to Dupixent®	Phase 3	Not yet recruiting	May 2027
NCT02755649	A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermat…	Phase 3	Completed	Jan 2017
NCT02414854	Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)	Phase 3	Completed	Jul 2017
NCT02528214	VENTURE: Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma	Phase 3	Completed	Sept 2017
NCT03345914	Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticostero…	Phase 3	Completed	Jun 2019
NCT02948959	VOYAGE: Evaluation of Dupilumab in Children With Uncontrolled Asthma	Phase 3	Completed	Aug 2020

Track dupilumab with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track dupilumab

Compare dupilumab vs lebrikizumab Compare dupilumab vs bimekizumab

FAQ

How many clinical trials are running for dupilumab?: ClinicalTrials.gov lists more than 16 phase 2–4 dupilumab trials. This page tracks the 16 largest by enrolment: 2 phase 2, 9 phase 3, and 5 phase 4 among them, with 3 actively recruiting. Updated daily.
Are there clinical trials for Dupixent?: Dupixent is the brand name for dupilumab, so dupilumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 dupilumab trials. This page tracks the 16 largest by enrolment: 2 phase 2, 9 phase 3, and 5 phase 4 among them, with 3 actively recruiting. Updated daily.
Where does this data come from?: All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare dupilumab against other drugs?: Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.

Upcoming readouts

Key dupilumab trials

Track dupilumab with ComplyRx

Related drug pipelines

FAQ

Be the first to access ComplyRx